Treatment of cystic ovarian disease with Naloxone in high production dairy cows
- 1 April 2008
- journal article
- clinical trial
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 31 (2) , 184-186
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Oestradiol Induced Inhibition of Neuroendocrine Marker Expression in Leydig Cells of Adult RatsReproduction in Domestic Animals, 2006
- Aetiology and pathogenesis of cystic ovarian follicles in dairy cattle: a reviewReproduction Nutrition Development, 2006
- An Update on Cystic Ovarian Degeneration in CattleReproduction in Domestic Animals, 2004
- Metabolic Control Through L Calcium Channel, PKC and Opioid Receptors Modulation by an Association of Naloxone and Calcium SaltsCurrent Drug Target - Immune, Endocrine & Metabolic Disorders, 2001
- High Levels of Endorphin and Related Pathologies of Veterinary Concern. A ReviewImmunopharmacology and Immunotoxicology, 2000
- Ovarian Follicular Cysts in Dairy CowsJournal of Dairy Science, 1997
- Opioids Modulate Progesterone Production in Prepubertal Bunaji Heifers1Biology of Reproduction, 1995
- Opioid modulation of the hypothalamo-pituitary-adrenal axis in dairy cowsDomestic Animal Endocrinology, 1992
- Opioid modulation of gonadotropin and prolactin secretion in domestic farm animalsDomestic Animal Endocrinology, 1991
- Inhibition of pituitary LH release resulting from endogenous opioid peptidesDomestic Animal Endocrinology, 1986